Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida

References

• Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61(1):191–199. doi:10.1002/hep.2738825142309
   PubMed Web of Science ®Google Scholar
• White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812–820 e815. doi:10.1053/j.gastro.2016.11.02027889576
   PubMed Web of Science ®Google Scholar
• https://seer.cancer.gov/statfacts/html/livibd.html Accessed 95 2019.
   Google Scholar
• Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J Registry Manag. 2011;38(4):201–205.23270094
   PubMedGoogle Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576. doi:10.1053/j.gastro.2007.04.06117570226
   PubMed Web of Science ®Google Scholar
• Ha J, Yan M, Aguilar M, et al. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer. 2016;122(16):2512–2523. doi:10.1002/cncr.v122.1627195481
   PubMed Web of Science ®Google Scholar
• Setiawan VW, Hernandez BY, Lu SC, et al. Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort. J Natl Cancer Inst. 2014;106:12. doi:10.1093/jnci/dju326
   Google Scholar
• Singal AG, Li X, Tiro J, et al. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 2015;128(1):90e91–97. doi:10.1016/j.amjmed.2014.07.027
   Web of Science ®Google Scholar
• Jones PD, Diaz C, Wang D, Gonzalez-Diaz J, Martin P, Kobetz E. The impact of race on survival after hepatocellular carcinoma in a diverse American population. Dig Dis Sci. 2018;63(2):515–528. doi:10.1007/s10620-017-4869-329275448
   PubMed Web of Science ®Google Scholar
• Rich NE, Hester C, Odewole M, et al. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2018.
   Web of Science ®Google Scholar
• Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006;98(12):1934–1939.17225837
   PubMed Web of Science ®Google Scholar
• Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg. 2010;145(12):1158–1163. doi:10.1001/archsurg.2010.27221173289
   PubMedGoogle Scholar
• Artinyan A, Mailey B, Sanchez-Luege N, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer. 2010;116(5):1367–1377. doi:10.1002/cncr.v116:520101732
   PubMed Web of Science ®Google Scholar
• Dillon ST, Bhasin MK, Feng X, Koh DW, Daoud SS. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med. 2013;11:239. doi:10.1186/1479-5876-11-23924283668
   PubMed Web of Science ®Google Scholar
• Di Poto C, He S, Varghese RS, et al. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection. PLoS One. 2018;13(3):e0192748. doi:10.1371/journal.pone.019274829538406
   PubMed Web of Science ®Google Scholar
• Major JM, Sargent JD, Graubard BI, et al. Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle. Ann Epidemiol. 2014;24(2):104–110. doi:10.1016/j.annepidem.2013.11.00624332863
   PubMed Web of Science ®Google Scholar
• Davila JA, Petersena NJ, Nelson HA, El-Serag HB. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003;56(5):487–493. doi:10.1016/S0895-4356(02)00605-412812824
   PubMed Web of Science ®Google Scholar
• Sonnenday CJ, Dimick JB, Schulick RD, Choti MA. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg. 2007;11(12):1636–1646. [ discussion 1646]. doi:10.1007/s11605-007-0315-817912593
   PubMed Web of Science ®Google Scholar
• https://fcds.med.miami.edu/inc/welcome.shtml# Accessed 95 2019.
   Google Scholar
• https://www.census.gov/acs/www/methodology/sample-size-and-data-quality/response-rates/ Accessed 9 5 2019.
   Google Scholar
• https://www2.census.gov/geo/pdfs/reference/GARM/Ch10GARM.pdf Accessed 95 2019.
   Google Scholar
• Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas – the Public Health Disparities Geocoding Project. Am J Public Health. 2002;92(7):1100–1102. doi:10.2105/AJPH.92.7.110012084688
   PubMed Web of Science ®Google Scholar
• Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471–482. doi:10.1093/aje/kwf06812196317
   PubMed Web of Science ®Google Scholar
• Spielman SE, Folch D, Nagle N. Patterns and causes of uncertainty in the American Community Survey. Appl Geogr. 2014;46:147–157. doi:10.1016/j.apgeog.2013.11.00225404783
   PubMed Web of Science ®Google Scholar
• http://www.floridahealth.gov/statistics-and-data/survey-data/behavioral-risk-factor-surveillance-system/reports/_documents/2013county/_documents/2013_summary.pdf Accessed 9 5 2019.
   Google Scholar
• Li C, Balluz LS, Okoro CA, et al. Surveillance of certain health behaviors and conditions among states and selected local areas – behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ. 2011;60(9):1–250.
   PubMedGoogle Scholar
• Pierannunzi C, Xu F, Wallace RC, et al. A methodological approach to small area estimation for the behavioral risk factor surveillance system. Prev Chronic Dis. 2016;13:E91. doi:10.5888/pcd13.15048027418213
   PubMed Web of Science ®Google Scholar
• https://www.cdc.gov/brfss/annual_data/2013/pdf/2013_dqr.pdf Accessed 95 2019.
   Google Scholar
• https://chronicdata.cdc.gov/browse?category=Health-Related+Quality+of+Life.
   Google Scholar
• https://www.cdc.gov/hrqol/pdfs/mhd.pdf Accessed 95 2019.
   Google Scholar
• https://www.srtr.org/transplant-centers/?query=&distance=50&location=&state=FL&recipientType=adult&organ=liver&sort=rating Accessed 95, 2019.
   Google Scholar
• Wong MS, Grande DT, Mitra N, et al. Racial differences in geographic access to medical care as measured by patient report and geographic information systems. Med Care. 2017;55(9):817–822. doi:10.1097/MLR.000000000000077428731892
   PubMed Web of Science ®Google Scholar
• Boscoe FP, Henry KA, Zdeb MS. A Nationwide comparison of driving distance versus straight-line distance to hospitals. Prof Geogr. 2012;64:2. doi:10.1080/00330124.2011.583586
   Web of Science ®Google Scholar
• Apparicio P, Gelb J, Dube AS, Kingham S, Gauvin L, Robitaille E. The approaches to measuring the potential spatial access to urban health services revisited: distance types and aggregation-error issues. Int J Health Geogr. 2017;16(1):32. doi:10.1186/s12942-017-0105-928830461
   PubMed Web of Science ®Google Scholar
• https://seer.cancer.gov/registrars/data-collection.html Accessed 952019.
   Google Scholar
• Sanoff HK, Chang Y, Stavas JM, Sturmer T, Lund J. Effectiveness of initial transarterial chemoembolization for hepatocellular carcinoma among medicare beneficiaries. J Natl Compr Canc Netw. 2015;13(9):1102–1110. doi:10.6004/jnccn.2015.013526358794
   PubMed Web of Science ®Google Scholar
• https://www.cdc.gov/brfss/annual_data/2013/pdf/codebook13_llcp.pdf Accessed 952019.
   Google Scholar
• Estevez J, Yang JD, Leong J, et al. Clinical features associated with survival outcome in African-American patients with hepatocellular carcinoma. Am J Gastroenterol. 2018.
   Web of Science ®Google Scholar
• Kim D, Li AA, Perumpail BJ, et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69(3):1064–1074. doi:10.1002/hep.v69.330014489
   PubMed Web of Science ®Google Scholar
• Yu JC, Neugut AI, Wang S, et al. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer. 2010;116(7):1801–1809. doi:10.1002/cncr.v116:720143441
   PubMed Web of Science ®Google Scholar
• Pinheiro PS, Williams M, Miller EA, Easterday S, Moonie S, Trapido EJ. Cancer survival among Latinos and the Hispanic Paradox. Cancer Causes Control. 2011;22(4):553–561. doi:10.1007/s10552-011-9727-621279543
   PubMed Web of Science ®Google Scholar
• Pruitt SL, Tiro JA, Xuan L, Lee SJ. Hispanic and immigrant paradoxes in U.S. breast cancer mortality: impact of neighborhood poverty and hispanic density. Int J Environ Res Public Health. 2016;13:12. doi:10.3390/ijerph13121238
   Web of Science ®Google Scholar
• Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018;67(1):401–421. doi:10.1002/hep.2948728859233
   PubMed Web of Science ®Google Scholar
• Sherman CB, Zhao W, Corley DA, Guy J. Utilization and accuracy of biopsy in patients with hepatocellular carcinoma in a community based setting. J Clin Gastroenterol Treat. 2016;2(2):026. doi:10.23937/2469-584X/1510026
   Google Scholar